These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6738937)

  • 41. No effect of preoperative paracetamol and codeine suppositories for pain after termination of pregnancies in general anaesthesia.
    Dahl V; Fjellanger F; Raeder JC
    Eur J Pain; 2000; 4(2):211-5. PubMed ID: 10957701
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early midtrimester pregnancy termination. A comparison of dilatation and evacuation and intravaginal prostaglandin E2.
    Robins J; Surrago EJ
    J Reprod Med; 1982 Jul; 27(7):415-9. PubMed ID: 6956734
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Priming of the cervix with prostaglandins in the first and second trimester].
    Brabec W
    Wien Klin Wochenschr; 1982 Oct; 94(20):554-8. PubMed ID: 7168176
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of abortion by condom-Foley catheter method in pregnant women with intra-uterine foetal death.
    Mekbib TA
    Ethiop Med J; 1994 Apr; 32(2):107-13. PubMed ID: 8033876
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Termination of pregnancy in patients with missed abortion and intrauterine dead fetuses by a single intracervical application of prostaglandin E2 in viscous gel.
    Ekman G; Forman A; Ulmsten U; Wingerup L
    Zentralbl Gynakol; 1980; 102(4):219-22. PubMed ID: 7467962
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: a randomized, controlled study.
    Ashok PW; Flett GM; Templeton A
    Am J Obstet Gynecol; 2000 Oct; 183(4):998-1002. PubMed ID: 11035353
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolism of 9-deoxo-16,16-dimethyl-9-methylene prostaglandin E2 in humans.
    Steffenrud S
    Drug Metab Dispos; 1983; 11(3):255-65. PubMed ID: 6135585
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma concentrations of 9-deoxo-16-dimethyl-9-methylene-PGE2 in rhesus monkeys after administration by various routes.
    Kimball FA; Cornette JC; Bundy GL; Kirton KT
    Prostaglandins; 1980 Sep; 20(3):559-69. PubMed ID: 7422900
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of 9-deoxo-16,16-dimethyl-9-methylene PGE2 on muscle contractile activity and collagen synthesis in the human cervix.
    Norström A; Bryman I; Lindblom B; Christensen NJ
    Prostaglandins; 1985 Mar; 29(3):337-46. PubMed ID: 4001435
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New gel for intracervical application of prostaglandin E2.
    Ulmsten U; Johansson O; Kirstein-Pedersen A; Stenberg P; Wingerup L
    Lancet; 1979 Feb; 1(8112):377. PubMed ID: 85020
    [No Abstract]   [Full Text] [Related]  

  • 52. Termination of early pregnancy. Future development.
    Bygdeman M; Christensen NJ; Gréen K; Zheng S; Lundström V
    Acta Obstet Gynecol Scand Suppl; 1983; 113():125-9. PubMed ID: 6574667
    [No Abstract]   [Full Text] [Related]  

  • 53. Rupture of the uterus following treatment with 16-16-dimethyl E 2 prostaglandin vagitories.
    Jerve F; Fylling P; Stenby S
    Prostaglandins; 1979 Jan; 17(1):121-3. PubMed ID: 441421
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Induced abortion with prostaglandin F2alpha and a new prostaglandin E2 derivative].
    Lichtenegger W
    Wien Med Wochenschr; 1977 Sep; 127(17):536-8. PubMed ID: 919566
    [No Abstract]   [Full Text] [Related]  

  • 55. New prostaglandin E2 analogue for pregnancy termination.
    Bygdeman M; Gréen K; Bergström S; Bundy G; Kimball F
    Lancet; 1979 May; 1(8126):1136. PubMed ID: 86850
    [No Abstract]   [Full Text] [Related]  

  • 56. Serum relaxin levels in prostaglandin E2 induced abortions.
    Quagliarello J; Cederqvist L; Steinetz B; Weiss G
    Prostaglandins; 1978 Dec; 16(6):1003-6. PubMed ID: 748978
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Sulprostone, an uterospecific prostaglandin E2 derivative. Significance for abortion with special reference to various administration forms].
    Schmidt-Gollwitzer M; Schüssler B; Schmidt-Gollwitzer K
    Arch Gynecol; 1979 Jul; 228(1-4):403. PubMed ID: 485390
    [No Abstract]   [Full Text] [Related]  

  • 58. [Intramural-intrauterine administration of prostaglandin E2 derivative for abortion induction in semi-hospitalized care in the operating room].
    Wiechell H
    Arch Gynecol; 1979 Jul; 228(1-4):409-10. PubMed ID: 485396
    [No Abstract]   [Full Text] [Related]  

  • 59. Metabolism of 16, 16-dimethyl-prostaglandin E2 in the human female.
    Steffenrud S
    Biochem Med; 1980 Dec; 24(3):274-92. PubMed ID: 7283984
    [No Abstract]   [Full Text] [Related]  

  • 60. [1st experiences with abortion induction using sulprostone, a prostaglandin E2 derivative].
    Gethmann U; Oberheuser F
    Arch Gynecol; 1979 Jul; 228(1-4):400-1. PubMed ID: 485388
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.